Document is current

Article History

Received: 12 April 2024

Accepted: 23 July 2024

First Online: 13 September 2024

Disclosure

: Marwan Fakih was involved in relevant financial activities outside the submitted work for AbbVie, Inc., AstraZeneca, Bayer Corporation, Bristol Myers Squibb, Eisai Inc., Entos, Inc.,; Incyte Corporation, Janssen, Merck, Mirati, Nouscom, Pfizer, Inc., Roche/Genentech, Taiho Oncology, and Xenthera, Inc. Yuman Fong is a scientific advisor to Medtronics, Imugene, Vergent Biosciences, XDemics, Theromics, Eureka Biologics, Iovance Biotherapeutics, and Savato Health. Thanh Dellinger received PIPAC nebulizers free of charge for this trial at City of Hope by Reger Inc company. Mustafa Raoof received grant funding from Exact biosciences for an investigator-initiated trial. Richard Whelan is a consultant for the Applied Medical Corporation with regard to endoscopic submucosal dissection (ESD), which is an advanced endoscopic procedure. He also is seeking support from this company for an investigator-initiated <i>ex vivo</i> animal study regarding ESD. This consultant work has nothing to do with PIPAC, peritoneal metastases, or the U.S. phase 1 study described in this report. Notably, this company also makes a type of laparoscopic port with an inflatable balloon near the tip. This happens to be the disposable port preferred by most surgeons performing PIPAC. The specific type of equipment used during PIPAC is not the subject matter of this report, nor is it germaine to the report. Richard Whelan has no relationship with Applied Medical regarding their laparoscopic ports or the PIPAC procedure. The remaining authors have no conflicts of interest.